IVF vs PATH
INVO Fertility, Inc. (IVF) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
INVO Fertility, Inc. (IVF) is a medical devices company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported IVF revenue for 2025-12-31 was $6.8M. Net income was -$23.3M. Revenue was up 4.7% from 2024-12-31 to 2025-12-31. IVF currently screens at market cap $2.8M.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
IVF currently screens at market cap $2.8M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the IVF and PATH stock pages for the full models.
Not investment advice.